We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

1.
Figure 2

Figure 2. From: Placebo adherence and mortality in the Hormone and Estrogen/Progestin Replacement Study.

Kaplan Meier curves of total mortality for higher-adherent (blue line) and lower-adherent (red line) placebo-allocated participants in the HERS study.

Amy M. Padula, et al. Am J Med. ;125(8):804-810.
2.
Figure 1

Figure 1. From: Placebo adherence and mortality in the Hormone and Estrogen/Progestin Replacement Study.

Distribution of total in-study adherence levels among placebo-allocated participants in the HERS study

Amy M. Padula, et al. Am J Med. ;125(8):804-810.
3.
Figure 3

Figure 3. From: Placebo adherence and mortality in the Hormone and Estrogen/Progestin Replacement Study.

Hazard ratios (95% CI) of total mortality for more-adherent versus less-adherent participants by cutpoints of adherence in the HERS study

Amy M. Padula, et al. Am J Med. ;125(8):804-810.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk